Papers/PMID:25499543
Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial.
Lancet (London, England)2015The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
all-trans-retinol — no detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“Similarly, mortality at 12 months (n=29 435) of age was not different between the vitamin A and placebo groups; relative risk 1·04 (95% CI 0·93–1·17; p=0·494).”
Quoted verbatim from Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial.. - Study
- RCT
- Participants
- 29,435
- Duration
- 12 months
- Dose
- single dose of 50,000 IU vitamin A
- Population
- Newborn infants in Tanzania randomised in the first 3 days of life to one 50,000 IU vitamin A dose or placebo; mortality to 12 months of age
Effect 1.04 risk ratio, 95% CI 0.93 to 1.17
Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial.2015PMID:25499543Permalink